Published in ACS Chem Biol on December 18, 2009
Quartz crystal microbalance with dissipation monitoring of supported lipid bilayers on various substrates. Nat Protoc (2010) 1.34
Mixing the right hepatitis C inhibitor cocktail. Trends Mol Med (2010) 0.91
Model cell membranes: Techniques to form complex biomimetic supported lipid bilayers via vesicle fusion. Curr Opin Colloid Interface Sci (2013) 0.81
Biomimetic supported lipid bilayers with high cholesterol content formed by α-helical peptide-induced vesicle fusion. J Mater Chem (2012) 0.80
Nonstructural protein 5A is incorporated into hepatitis C virus low-density particle through interaction with core protein and microtubules during intracellular transport. PLoS One (2014) 0.78
Cholesterol-Enriched Domain Formation Induced by Viral-Encoded, Membrane-Active Amphipathic Peptide. Biophys J (2016) 0.78
Peptide-induced formation of a tethered lipid bilayer membrane on mesoporous silica. Eur Biophys J (2014) 0.77
Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics. Biomaterials (2015) 0.76
Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection. N Engl J Med (2014) 9.45
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection. N Engl J Med (2015) 3.13
Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog (2010) 2.62
Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis. Nat Biotechnol (2008) 2.52
Structural linkage between ligand discrimination and receptor activation by type I interferons. Cell (2011) 2.39
Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication. J Virol (2003) 2.20
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. N Engl J Med (2015) 2.17
An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication. J Virol (2004) 1.99
Synthesis of well-defined hydrogel networks using click chemistry. Chem Commun (Camb) (2006) 1.79
The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C. Liver Transpl (2009) 1.64
Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users. J Infect Dis (2010) 1.58
Calcium drives fusion of SNARE-apposed bilayers. Cell Biol Int (2004) 1.58
Regulation of the water channel aquaporin-1: isolation and reconstitution of the regulatory complex. Cell Biol Int (2004) 1.57
Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis. Hepatology (2015) 1.48
A nucleotide binding motif in hepatitis C virus (HCV) NS4B mediates HCV RNA replication. J Virol (2004) 1.41
Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells. Clin Cancer Res (2005) 1.40
Design and fabrication of an artificial cornea based on a photolithographically patterned hydrogel construct. Biomed Microdevices (2007) 1.38
Structure and composition of the fusion pore. Biophys J (2003) 1.38
TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication. J Biol Chem (2007) 1.36
Quartz crystal microbalance with dissipation monitoring of supported lipid bilayers on various substrates. Nat Protoc (2010) 1.34
In vivo antiviral efficacy of prenylation inhibitors against hepatitis delta virus. J Clin Invest (2003) 1.33
Hepatitis C virus core protein associates with detergent-resistant membranes distinct from classical plasma membrane rafts. J Virol (2004) 1.30
Vesicle adsorption and lipid bilayer formation on glass studied by atomic force microscopy. Langmuir (2004) 1.29
A drug-controllable tag for visualizing newly synthesized proteins in cells and whole animals. Proc Natl Acad Sci U S A (2008) 1.29
Precursor and temperature modulation of fatty acid composition and growth of Listeria monocytogenes cold-sensitive mutants with transposon-interrupted branched-chain alpha-keto acid dehydrogenase. Microbiology (2005) 1.24
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial. J Viral Hepat (2014) 1.23
Identification of a class of HCV inhibitors directed against the nonstructural protein NS4B. Sci Transl Med (2010) 1.20
Isolation and transcriptional profiling of purified hepatic cells derived from human embryonic stem cells. Stem Cells (2008) 1.19
Reconstituted fusion pore. Biophys J (2003) 1.19
Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California. J Gastroenterol Hepatol (2013) 1.17
A prenylation inhibitor prevents production of infectious hepatitis delta virus particles. J Virol (2002) 1.13
Simplified RNA secondary structure mapping by automation of SHAPE data analysis. Nucleic Acids Res (2011) 1.12
The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein. Virology (2011) 1.10
Potential for hepatitis C virus resistance to nitazoxanide or tizoxanide. Antimicrob Agents Chemother (2008) 1.09
Kinetics of oligonucleotide hybridization to photolithographically patterned DNA arrays. Anal Biochem (2006) 1.09
Development of novel therapies for hepatitis C. Antiviral Res (2010) 1.09
A Rab-GAP TBC domain protein binds hepatitis C virus NS5A and mediates viral replication. J Virol (2007) 1.08
Mechanisms of HCV survival in the host. Nat Rev Gastroenterol Hepatol (2009) 1.07
The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation. Gastroenterology (2009) 1.05
Toward the development of an artificial cornea: improved stability of interpenetrating polymer networks. J Biomed Mater Res B Appl Biomater (2011) 1.02
Progress in the development of interpenetrating polymer network hydrogels. Polym Adv Technol (2008) 1.02
Glucose-permeable interpenetrating polymer network hydrogels for corneal implant applications: a pilot study. Curr Eye Res (2008) 0.99
Role for ADP ribosylation factor 1 in the regulation of hepatitis C virus replication. J Virol (2010) 0.97
A small molecule inhibits HCV replication and alters NS4B's subcellular distribution. Antiviral Res (2010) 0.96
Antibody conjugated supported lipid bilayer for capturing and purification of viable tumor cells in blood for subsequent cell culture. Biomaterials (2013) 0.96
The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection. Hepatology (2008) 0.95
Development of hydrogel-based keratoprostheses: a materials perspective. Biotechnol Prog (2008) 0.95
Binding dynamics of hepatitis C virus' NS5A amphipathic peptide to cell and model membranes. J Virol (2007) 0.94
Structural map of a microRNA-122: hepatitis C virus complex. J Virol (2011) 0.92
The dramatic effect of architecture on the self-assembly of block copolymers at interfaces. Langmuir (2005) 0.91
The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy. PLoS One (2009) 0.91
Viral infection of human progenitor and liver-derived cells encapsulated in three-dimensional PEG-based hydrogel. Biomed Mater (2008) 0.90
HMG-CoA reductase inhibition causes increased necrosis and apoptosis in an in vivo mouse glioblastoma multiforme model. Anticancer Res (2009) 0.89
Prenylation inhibitors: a novel class of antiviral agents. J Antimicrob Chemother (2003) 0.89
Transdifferentiation of adipose-derived stem cells into hepatocytes: a new approach. Liver Int (2010) 0.89
Alpha-helical peptide-induced vesicle rupture revealing new insight into the vesicle fusion process as monitored in situ by quartz crystal microbalance-dissipation and reflectometry. Anal Chem (2009) 0.89
The Future of HCV Therapy: NS4B as an Antiviral Target. Viruses (2010) 0.87
Hydrophobic nanoparticles improve permeability of cell-encapsulating poly(ethylene glycol) hydrogels while maintaining patternability. Proc Natl Acad Sci U S A (2010) 0.87
Fluid biomembranes supported on nanoporous aerogel/xerogel substrates. Langmuir (2004) 0.87
Morphology of Photopolymerized End-linked Poly(ethylene glycol) Hydrogels by Small Angle X-ray Scattering. Macromolecules (2010) 0.86
Employing an amphipathic viral peptide to create a lipid bilayer on Au and TiO2. J Am Chem Soc (2007) 0.86
Grafting of cross-linked hydrogel networks to titanium surfaces. ACS Appl Mater Interfaces (2014) 0.86
In situ formation and characterization of poly(ethylene glycol)-supported lipid bilayers on gold surfaces. Langmuir (2004) 0.85
Antibody binding to a tethered vesicle assembly using QCM-D. Anal Chem (2009) 0.84
The atomic force microscope in the study of membrane fusion and exocytosis. Methods Cell Biol (2002) 0.84
Celecoxib but not rofecoxib inhibits the growth of transformed cells in vitro. Clin Cancer Res (2004) 0.84
The hepatitis C virus (HCV) NS4B RNA binding inhibitor clemizole is highly synergistic with HCV protease inhibitors. J Infect Dis (2010) 0.83
Quantitative analysis of tethered vesicle assemblies by quartz crystal microbalance with dissipation monitoring: Binding dynamics and bound water content. Langmuir (2006) 0.83
Employing two different quartz crystal microbalance models to study changes in viscoelastic behavior upon transformation of lipid vesicles to a bilayer on a gold surface. Anal Chem (2007) 0.83
Patch clamped single pancreatic zymogen granules: direct measurements of ion channel activities at the granule membrane. Pancreatology (2005) 0.83
Bioactive interpenetrating polymer network hydrogels that support corneal epithelial wound healing. J Biomed Mater Res A (2009) 0.82
The reliable targeting of specific drug release profiles by integrating arrays of different albumin-encapsulated microsphere types. Biomaterials (2009) 0.82
Preparation and characterization of glycoacrylate-based polymer-tethered lipid bilayers on benzophenone-modified substrates. Langmuir (2008) 0.82
Scanning ion conductance microscopy for imaging biological samples in liquid: a comparative study with atomic force microscopy and scanning electron microscopy. Micron (2012) 0.82
Hepatitis d. Curr Treat Options Gastroenterol (2007) 0.82
Vesicle adhesion and rupture on silicon oxide: influence of freeze-thaw pretreatment. Langmuir (2014) 0.81
Fluid supported lipid bilayers containing monosialoganglioside GM1: a QCM-D and FRAP study. Colloids Surf B Biointerfaces (2006) 0.81
Quartz resonator signatures under Newtonian liquid loading for initial instrument check. J Colloid Interface Sci (2007) 0.81
Kinetics of oligonucleotide hybridization to DNA probe arrays on high-capacity porous silica substrates. Biophys J (2007) 0.81
Use of the unroofing technique for atomic force microscopic imaging of the intra-cellular cytoskeleton under aqueous conditions. J Electron Microsc (Tokyo) (2012) 0.80
Fabrication of a planar zwitterionic lipid bilayer on titanium oxide. Langmuir (2010) 0.80
Interfacial binding dynamics of bee venom phospholipase A2 investigated by dynamic light scattering and quartz crystal microbalance. Langmuir (2010) 0.80
Isolation of human fetal liver progenitors and their enhanced proliferation by three-dimensional coculture with endothelial cells. Tissue Eng Part A (2008) 0.80
Creation of lipid partitions by deposition of amphipathic viral peptides. Langmuir (2007) 0.80